Growth Metrics

Bio-Techne (TECH) Net Cash Flow (2016 - 2026)

Bio-Techne has reported Net Cash Flow over the past 17 years, most recently at $27.5 million for Q4 2025.

  • For Q4 2025, Net Cash Flow rose 708.09% year-over-year to $27.5 million; the TTM value through Dec 2025 reached -$16.2 million, down 136.03%, while the annual FY2025 figure was -$1.5 million, 94.21% up from the prior year.
  • Net Cash Flow for Q4 2025 was $27.5 million at Bio-Techne, up from -$16.0 million in the prior quarter.
  • Over five years, Net Cash Flow peaked at $54.4 million in Q2 2023 and troughed at -$46.9 million in Q1 2022.
  • A 5-year average of $650600.0 and a median of $5.6 million in 2022 define the central range for Net Cash Flow.
  • Biggest five-year swings in Net Cash Flow: crashed 606.1% in 2023 and later soared 708.09% in 2025.
  • Year by year, Net Cash Flow stood at $12.4 million in 2021, then tumbled by 163.62% to -$7.9 million in 2022, then crashed by 177.2% to -$22.0 million in 2023, then soared by 79.4% to -$4.5 million in 2024, then soared by 708.09% to $27.5 million in 2025.
  • Business Quant data shows Net Cash Flow for TECH at $27.5 million in Q4 2025, -$16.0 million in Q3 2025, and $8.2 million in Q2 2025.